GRCE
Grace Therapeutics, Inc · NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals
$3.57+$0.24 (+7.21%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for GRCE is being prepared.
Key Stats
Key Stats
Open
$3.51
Day High
$3.69
Day Low
$3.29
Prev Close
$3.33
Volume
0
Avg Volume
1.3M
Day Change
+$0.24
Change %
+7.21%
Fundamentals
Fundamentals
P/B
0.47
EPS (TTM)
$-0.36
Market Cap
$55M
52-Wk Range
$1.75 — $5.18
Earnings History
Insider Activity
Who Owns This Stock
Who Owns GRCE
Other77.5%16 holders
Dealer / Bank10.5%4 holders
Passive / Index8.5%1 holder
Systematic / Quant2.6%1 holder
Tactical / Macro0.9%1 holder
Based on Q4 2025 13F filings + AC behavioral model
23 institutional holders
Top Holders
0.0%$4076.6B
0.0%$2319.5B
+83.2%$2221.3B
+83.2%$2221.3B
0.0%$1711.7B
$1462.7B
+3.7%$1449.2B
-64.7%$826.6B
+53.5%$449.0B
+55.1%$147.6B
$105.6B
$88.0B
$38.7B
-97.8%$30.5B
$9.4B
$6.7B
$2.1B
$2.0B
0.0%$360M
0.0%$349M
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(77.5%)
●
—Dealer / Bank(10.5%)
●
FacilitatingPassive / Index(8.5%)
●
HoldsSystematic / Quant(2.6%)
●
De-risking (mechanical)Tactical / Macro(0.9%)
●
Reducing rapidly9% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus7 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows18 increased/new, 2 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of GRCE on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.